| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.988 | 0.003 | 0.991 | Analgesic | 0.979 0.004 DB00318 0.991 0.003 DBMET02313 0.988 0.003 DBMET00649 0.955 0.004 DB06409 0.588 0.029 DBMET00462 | DBMET02313 | |
| 0.975 | 0.001 | 0.991 | Analgesic, opioid | 0.939 0.002 DB00318 0.991 0.001 DBMET02313 0.958 0.001 DBMET00649 0.89 0.002 DB06409 0.146 0.015 DBMET00462 | DBMET02313 | |
| 0.97 | 0.002 | 0.973 | Psychostimulant | 0.97 0.002 DB00318 0.578 0.007 DBMET02313 0.928 0.002 DBMET00649 0.973 0.002 DB06409 0.489 0.012 DBMET00462 | DB06409 | |
| 0.881 | 0.002 | 0.881 | Anesthetic general | 0.87 0.002 DB00318 0.442 0.012 DBMET02313 0.805 0.002 DBMET00649 0.85 0.002 DB06409 0.333 0.027 DBMET00462 | ||
| 0.877 | 0.002 | 0.877 | Opioid agonist | 0.816 0.002 DB00318 0.827 0.002 DBMET02313 0.842 0.002 DBMET00649 0.754 0.002 DB06409 0.054 0.036 DBMET00462 | ||
| 0.87 | 0.001 | 0.87 | Opioid antagonist | 0.839 0.002 DB00318 0.819 0.002 DBMET02313 0.853 0.002 DBMET00649 0.83 0.002 DB06409 0.153 0.025 DBMET00462 | ||
| 0.858 | 0.001 | 0.858 | Opioid mu receptor antagonist | 0.815 0.002 DB00318 0.795 0.002 DBMET02313 0.834 0.001 DBMET00649 0.804 0.002 DB06409 0.102 0.031 DBMET00462 | ||
| 0.857 | 0.001 | 0.857 | Opioid mu receptor agonist | 0.778 0.002 DB00318 0.775 0.002 DBMET02313 0.8 0.001 DBMET00649 0.708 0.002 DB06409 0.043 0.037 DBMET00462 | ||
| 0.858 | 0.004 | 0.858 | Spasmolytic | 0.844 0.004 DB00318 0.479 0.026 DBMET02313 0.759 0.005 DBMET00649 0.846 0.004 DB06409 0.211 0.111 DBMET00462 | ||
| 0.798 | 0.001 | 0.798 | Opioid delta receptor antagonist | 0.769 0.002 DB00318 0.729 0.002 DBMET02313 0.783 0.002 DBMET00649 0.73 0.002 DB06409 0.057 0.048 DBMET00462 | ||
| 0.778 | 0.001 | 0.778 | Opioid kappa receptor antagonist | 0.75 0.001 DB00318 0.696 0.002 DBMET02313 0.761 0.001 DBMET00649 0.691 0.002 DB06409 0.153 0.016 DBMET00462 | ||
| 0.77 | 0.002 | 0.77 | Opioid delta receptor agonist | 0.698 0.002 DB00318 0.609 0.003 DBMET02313 0.733 0.002 DBMET00649 0.639 0.002 DB06409 | ||
| 0.733 | 0.005 | 0.737 | 5 Hydroxytryptamine release stimulant | 0.728 0.005 DB00318 0.43 0.04 DBMET02313 0.574 0.017 DBMET00649 0.737 0.005 DB06409 0.198 0.123 DBMET00462 | DB06409 | |
| 0.725 | 0.003 | 0.725 | Sigma receptor antagonist | 0.631 0.004 DB00318 0.369 0.005 DBMET02313 0.664 0.004 DBMET00649 0.19 0.009 DB06409 | ||
| 0.698 | 0.003 | 0.698 | Alpha 2a adrenoreceptor antagonist | 0.61 0.003 DB00318 0.145 0.023 DBMET02313 0.689 0.003 DBMET00649 | ||
| 0.659 | 0.001 | 0.659 | Opioid kappa receptor agonist | 0.6 0.001 DB00318 0.522 0.002 DBMET02313 0.61 0.001 DBMET00649 0.502 0.002 DB06409 0.058 0.019 DBMET00462 | ||
| 0.618 | 0.004 | 0.66 | Alpha 2 adrenoreceptor antagonist | 0.66 0.003 DB00318 0.128 0.034 DBMET02313 0.594 0.004 DBMET00649 | DB00318 | |
| 0.622 | 0.029 | 0.805 | Transcription factor NF kappa B inhibitor | 0.624 0.028 DB00318 0.228 0.144 DBMET02313 0.59 0.032 DBMET00649 0.805 0.012 DB06409 0.666 0.024 DBMET00462 | DB06409 | |
| 0.553 | 0.005 | 0.553 | Sigma receptor agonist | 0.553 0.005 DB00318 0.463 0.013 DBMET02313 0.172 0.072 DBMET00649 0.355 0.029 DB06409 | ||
| 0.491 | 0.036 | 0.532 | Immunosuppressant | 0.466 0.043 DB00318 0.405 0.06 DBMET02313 0.522 0.027 DBMET00649 0.532 0.025 DB06409 0.465 0.043 DBMET00462 | DB06409 | |
| 0.486 | 0.093 | 0.674 | Antiinflammatory | 0.47 0.101 DB00318 0.508 0.084 DBMET02313 0.466 0.103 DBMET00649 0.674 0.036 DB06409 0.541 0.071 DBMET00462 | DB06409 | |
| 0.417 | 0.026 | 0.422 | Hypoxia-inducible factor 1 alpha inhibitor | 0.422 0.025 DB00318 0.341 0.048 DBMET00649 0.37 0.039 DB06409 | DB00318 | |
| 0.382 | 0.018 | 0.44 | P-glycoprotein inhibitor | 0.44 0.012 DB00318 0.174 0.086 DBMET02313 0.288 0.031 DBMET00649 0.259 0.039 DB06409 0.246 0.043 DBMET00462 | DB00318 | |
| 0.356 | 0.009 | 0.356 | Antipruritic | 0.303 0.014 DB00318 0.15 0.094 DBMET02313 0.331 0.01 DBMET00649 0.224 0.035 DB06409 | ||
| 0.351 | 0.006 | 0.64 | Expectorant | 0.466 0.004 DB00318 0.095 0.075 DBMET02313 0.314 0.008 DBMET00649 0.64 0.002 DB06409 0.122 0.049 DBMET00462 | DB06409 | |
| 0.327 | 0.003 | 0.327 | Toll-Like receptor 4 antagonist | 0.28 0.003 DB00318 0.229 0.004 DBMET02313 0.306 0.003 DBMET00649 0.29 0.003 DB06409 0.151 0.02 DBMET00462 | ||
| 0.319 | 0.013 | 0.338 | Interleukin 6 antagonist | 0.302 0.014 DB00318 0.185 0.05 DBMET02313 0.255 0.022 DBMET00649 0.338 0.011 DB06409 0.218 0.032 DBMET00462 | DB06409 | |
| 0.302 | 0.014 | 0.302 | Acetylcholine M1 receptor antagonist | 0.22 0.034 DB00318 0.214 0.037 DBMET00649 | ||
| 0.323 | 0.036 | 0.445 | Nitric oxide antagonist | 0.319 0.037 DB00318 0.276 0.045 DBMET02313 0.295 0.042 DBMET00649 0.445 0.02 DB06409 0.423 0.023 DBMET00462 | DB06409 | |
| 0.283 | 0.009 | 0.283 | Toll-Like receptor antagonist | 0.269 0.011 DB00318 0.252 0.015 DBMET00649 0.116 0.091 DB06409 | ||
| 0.388 | 0.12 | 0.639 | Apoptosis agonist | 0.406 0.111 DB00318 0.341 0.144 DBMET00649 0.467 0.085 DB06409 0.639 0.041 DBMET00462 | DBMET00462 | |
| 0.277 | 0.017 | 0.432 | Alpha adrenoreceptor antagonist | 0.432 0.008 DB00318 0.222 0.024 DBMET00649 | DB00318 | |
| 0.288 | 0.052 | 0.316 | 5 Hydroxytryptamine uptake stimulant | 0.316 0.038 DB00318 0.314 0.038 DBMET00649 | DB00318 | |
| 0.28 | 0.07 | 0.61 | Antioxidant | 0.235 0.092 DB00318 0.195 0.117 DBMET02313 0.314 0.057 DBMET00649 0.494 0.021 DB06409 0.61 0.011 DBMET00462 | DBMET00462 | |
| 0.214 | 0.009 | 0.214 | Dopamine agonist | 0.169 0.013 DB00318 0.134 0.017 DBMET02313 0.191 0.011 DBMET00649 0.09 0.032 DB06409 | ||
| 0.23 | 0.025 | 0.23 | Cholinergic antagonist | 0.187 0.036 DB00318 0.174 0.04 DBMET00649 | ||
| 0.202 | 0.008 | 0.202 | Prolactin inhibitor | 0.165 0.017 DB00318 0.096 0.06 DBMET02313 0.178 0.013 DBMET00649 | ||
| 0.217 | 0.027 | 0.217 | Acetylcholine antagonist | 0.176 0.038 DB00318 0.167 0.042 DBMET00649 | ||
| 0.182 | 0.005 | 0.182 | Dopamine D2 agonist | 0.132 0.008 DB00318 0.166 0.006 DBMET02313 0.062 0.02 DBMET00649 0.11 0.009 DB06409 | ||
| 0.272 | 0.095 | 0.338 | Caspase 3 stimulant | 0.301 0.078 DB00318 0.219 0.144 DBMET00649 0.338 0.063 DB06409 0.309 0.074 DBMET00462 | DB06409 | |
| 0.213 | 0.037 | 0.314 | Protein kinase stimulant | 0.214 0.037 DB00318 0.205 0.04 DBMET00649 0.314 0.015 DB06409 0.214 0.037 DBMET00462 | DB06409 | |
| 0.212 | 0.041 | 0.244 | Cholinergic | 0.244 0.03 DB00318 0.218 0.039 DBMET00649 | DB00318 | |
| 0.187 | 0.017 | 0.187 | Antineoplastic alkaloid | 0.184 0.018 DB00318 0.08 0.066 DBMET02313 0.164 0.024 DBMET00649 0.089 0.056 DB06409 | ||
| 0.207 | 0.061 | 0.388 | Hepatoprotectant | 0.215 0.056 DB00318 0.189 0.072 DBMET02313 0.179 0.081 DBMET00649 0.388 0.014 DB06409 0.314 0.026 DBMET00462 | DB06409 | |
| 0.164 | 0.021 | 0.197 | Dopamine D2 antagonist | 0.197 0.017 DB00318 0.088 0.036 DBMET00649 | DB00318 | |
| 0.257 | 0.122 | 0.361 | Vasodilator, peripheral | 0.361 0.069 DB00318 0.25 0.127 DB06409 | DB00318 | |
| 0.157 | 0.024 | 0.181 | Dopamine antagonist | 0.181 0.021 DB00318 0.085 0.045 DBMET00649 | DB00318 | |
| 0.132 | 0.003 | 0.132 | Prolactin release inhibitor | 0.125 0.003 DB00318 0.118 0.003 DBMET02313 0.102 0.004 DBMET00649 0.1 0.004 DB06409 | ||
| 0.165 | 0.036 | 0.165 | Acetylcholine muscarinic antagonist | 0.134 0.055 DB00318 0.108 0.08 DBMET00649 | ||
| 0.139 | 0.016 | 0.139 | Dopamine D1 antagonist | 0.089 0.029 DB00318 0.075 0.036 DBMET00649 | ||
| 0.144 | 0.022 | 0.144 | Acetylcholine nicotinic antagonist | 0.137 0.024 DB00318 0.126 0.028 DBMET00649 | ||
| 0.217 | 0.095 | 0.372 | Tumour necrosis factor alpha release inhibitor | 0.347 0.039 DB00318 0.28 0.061 DBMET02313 0.155 0.152 DBMET00649 0.372 0.032 DB06409 | DB06409 | |
| 0.123 | 0.008 | 0.123 | Dopamine D5 antagonist | 0.087 0.011 DB00318 0.052 0.024 DBMET02313 0.079 0.012 DBMET00649 | ||
| 0.148 | 0.036 | 0.185 | Antiadrenergic | 0.185 0.027 DB00318 0.148 0.036 DBMET00649 | DB00318 | |
| 0.138 | 0.034 | 0.276 | Antineoplastic antibiotic | 0.125 0.037 DB00318 0.071 0.064 DBMET02313 0.139 0.033 DBMET00649 0.203 0.021 DB06409 0.276 0.011 DBMET00462 | DBMET00462 | |
| 0.155 | 0.052 | 0.191 | Acetylcholinesterase inhibitor | 0.191 0.036 DB00318 0.108 0.092 DBMET00649 0.104 0.099 DBMET00462 | DB00318 | |
| 0.196 | 0.101 | 0.489 | Free radical scavenger | 0.196 0.101 DBMET00649 0.431 0.024 DB06409 0.489 0.017 DBMET00462 | DBMET00462 | |
| 0.097 | 0.006 | 0.097 | Nociceptin (N/OFQ) receptor antagonist | 0.059 0.011 DB00318 0.037 0.024 DBMET02313 0.065 0.009 DBMET00649 | ||
| 0.117 | 0.026 | 0.121 | Alpha 2d adrenoreceptor antagonist | 0.121 0.023 DB00318 0.103 0.043 DBMET02313 0.114 0.029 DBMET00649 | DB00318 | |
| 0.131 | 0.042 | 0.178 | Alpha 2c adrenoreceptor antagonist | 0.178 0.023 DB00318 0.102 0.064 DBMET00649 | DB00318 | |
| 0.129 | 0.041 | 0.169 | Adrenaline antagonist | 0.169 0.03 DB00318 0.13 0.041 DBMET00649 | DB00318 | |
| 0.142 | 0.065 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.133 0.105 DB00318 0.135 0.094 DBMET00649 0.139 0.076 DB06409 | ||
| 0.1 | 0.024 | 0.1 | Neuronal nicotinic receptor antagonist | 0.093 0.028 DB00318 0.088 0.03 DBMET00649 | ||
| 0.195 | 0.123 | 0.473 | Immunostimulant | 0.163 0.144 DBMET02313 0.177 0.135 DBMET00649 0.473 0.033 DB06409 0.375 0.057 DBMET00462 | DB06409 | |
| 0.2 | 0.136 | 0.215 | Tyrosine 3 hydroxylase inhibitor | 0.215 0.111 DBMET00649 | DBMET00649 | |
| 0.089 | 0.028 | 0.099 | Glycine receptor agonist | 0.081 0.037 DB00318 0.099 0.022 DBMET00649 0.083 0.035 DB06409 | DBMET00649 | |
| 0.115 | 0.054 | 0.127 | Electron transport complex I inhibitor | 0.127 0.039 DB00318 0.104 0.074 DBMET00649 0.12 0.047 DBMET00462 | DB00318 | |
| 0.183 | 0.123 | 0.382 | Peptidyltransferase inhibitor | 0.165 0.157 DB00318 0.184 0.122 DBMET00649 0.363 0.01 DB06409 0.382 0.008 DBMET00462 | DBMET00462 | |
| 0.123 | 0.065 | 0.147 | Adenylate cyclase inhibitor | 0.147 0.047 DBMET00649 | DBMET00649 | |
| 0.155 | 0.098 | 0.155 | Lipocortins synthesis antagonist | 0.152 0.102 DB00318 0.142 0.117 DBMET00649 | ||
| 0.098 | 0.042 | 0.14 | ATPase (Vacuolar H+) inhibitor | 0.104 0.035 DB00318 0.102 0.037 DBMET00649 0.115 0.023 DB06409 0.14 0.01 DBMET00462 | DBMET00462 | |
| 0.125 | 0.072 | 0.125 | MAO inhibitor | 0.115 0.077 DBMET00649 | ||
| 0.115 | 0.064 | 0.123 | Estrogen antagonist | 0.105 0.086 DB00318 0.116 0.062 DBMET00649 0.123 0.049 DBMET00462 | DBMET00462 | |
| 0.104 | 0.057 | 0.104 | Estrogen receptor beta antagonist | 0.094 0.076 DB00318 0.101 0.063 DBMET00649 0.093 0.077 DBMET00462 | ||
| 0.051 | 0.005 | 0.083 | Dopamine D1 agonist | 0.036 0.006 DB00318 0.042 0.005 DBMET02313 0.083 0.004 DBMET00649 0.046 0.005 DB06409 | DBMET00649 | |
| 0.135 | 0.09 | 0.52 | NOS3 expression enhancer | 0.225 0.032 DB06409 0.52 0.005 DBMET00462 | DBMET00462 | |
| 0.098 | 0.057 | 0.272 | Breast cancer-resistant protein inhibitor | 0.124 0.037 DB00318 0.272 0.008 DBMET02313 0.107 0.049 DBMET00649 | DBMET02313 | |
| 0.138 | 0.1 | 0.233 | Melanin inhibitor | 0.167 0.062 DBMET00649 0.182 0.05 DB06409 0.233 0.031 DBMET00462 | DBMET00462 | |
| 0.106 | 0.07 | 0.106 | Cystathionine beta-synthase inhibitor | 0.095 0.083 DB00318 | ||
| 0.097 | 0.062 | 0.097 | Creatine kinase inhibitor | 0.089 0.073 DBMET00649 | ||
| 0.054 | 0.027 | 0.108 | Nicotinic receptor alpha4 subunit antagonist | 0.049 0.035 DB00318 0.108 0.007 DBMET00649 | DBMET00649 | |
| 0.03 | 0.004 | 0.037 | NMDA receptor phencyclidine site antagonist | 0.026 0.005 DB00318 0.037 0.004 DBMET00649 | DBMET00649 | |
| 0.206 | 0.18 | 0.206 | Sodium/bile acid cotransporter inhibitor | 0.201 0.186 DBMET00649 | ||
| 0.029 | 0.01 | 0.035 | Nociceptin (N/OFQ) receptor agonist | 0.035 0.009 DBMET00649 | DBMET00649 | |
| 0.165 | 0.151 | 0.238 | DNA damaging | 0.174 0.14 DBMET00649 0.238 0.087 DBMET00462 | DBMET00462 | |
| 0.114 | 0.1 | 0.217 | Lipid peroxidase inhibitor | 0.14 0.075 DBMET00649 0.217 0.035 DB06409 0.16 0.062 DBMET00462 | DB06409 | |
| 0.079 | 0.067 | 0.087 | CC chemokine 5 receptor agonist | 0.087 0.043 DBMET02313 0.08 0.065 DBMET00649 | DBMET02313 | |
| 0.075 | 0.065 | 0.148 | Glycine receptor antagonist | 0.075 0.065 DBMET02313 0.081 0.055 DBMET00649 0.089 0.044 DB06409 0.148 0.008 DBMET00462 | DBMET00462 | |
| 0.051 | 0.042 | 0.051 | Nicotinic receptor alpha7 subunit antagonist | 0.05 0.044 DB00318 0.049 0.046 DBMET00649 | ||
| 0.053 | 0.046 | 0.062 | Dopamine uptake inhibitor | 0.062 0.037 DB00318 | DB00318 | |
| 0.088 | 0.083 | 0.09 | Anabolic | 0.09 0.078 DBMET00649 | DBMET00649 | |
| 0.088 | 0.083 | 0.088 | Nav1.1 sodium channel blocker | |||
| 0.033 | 0.031 | 0.061 | Nicotinic receptor beta4 subunit antagonist | 0.061 0.012 DBMET00649 | DBMET00649 | |
| 0.094 | 0.095 | 0.203 | Alkylator | 0.203 0.025 DB06409 0.106 0.082 DBMET00462 | DB06409 | |
| 0.041 | 0.043 | 0.043 | Dopamine transporter inhibitor | 0.043 0.039 DB00318 | DB00318 | |
| 0.189 | 0.194 | 0.467 | Apoptosis antagonist | 0.202 0.176 DBMET00649 0.368 0.048 DB06409 0.467 0.025 DBMET00462 | DBMET00462 | |
| 0.052 | 0.062 | 0.06 | Lipocortins synthesis agonist | 0.06 0.035 DB06409 | DB06409 | |
| 0.092 | 0.106 | 0.109 | Microtubule formation inhibitor | 0.108 0.077 DB00318 0.109 0.076 DB06409 0.109 0.075 DBMET00462 | DBMET00462 | |
| 0.022 | 0.037 | 0.029 | Nicotinic alpha3beta4 receptor agonist | 0.029 0.022 DBMET00649 | DBMET00649 | |
| 0.191 | 0.206 | 0.35 | Interleukin 2 agonist | 0.35 0.045 DB06409 0.332 0.054 DBMET00462 | DB06409 | |
| 0.039 | 0.056 | 0.159 | Protein 50S ribosomal subunit inhibitor | 0.099 0.013 DB06409 0.159 0.006 DBMET00462 | DBMET00462 | |
| 0.05 | 0.069 | 0.067 | Nitric oxide donor | 0.067 0.037 DB06409 | DB06409 | |
| 0.029 | 0.052 | 0.106 | Dopamine D5 agonist | 0.106 0.004 DBMET00649 | DBMET00649 | |
| 0.136 | 0.161 | 0.15 | Neurotrophic factor enhancer | 0.15 0.138 DBMET00462 | DBMET00462 | |
| 0.003 | 0.036 | 0.021 | Antibiotic Macrolide-like | 0.012 0.011 DB06409 0.021 0.006 DBMET00462 | DBMET00462 | |
| 0.076 | 0.109 | 0.105 | Alpha 2b adrenoreceptor antagonist | 0.105 0.07 DB00318 | DB00318 | |
| 0.041 | 0.077 | 0.054 | Androgen agonist | 0.054 0.05 DBMET00649 | DBMET00649 | |
| 0.025 | 0.067 | 0.066 | Antibiotic Aminoglycoside-like | 0.065 0.007 DB06409 0.066 0.007 DBMET00462 | DBMET00462 | |
| 0.045 | 0.096 | 0.129 | Na+ K+ transporting ATPase inhibitor | 0.071 0.059 DBMET00649 0.084 0.047 DB06409 0.129 0.012 DBMET00462 | DBMET00462 | |
| 0.083 | 0.135 | 0.215 | Cyclooxygenase 3 inhibitor | 0.11 0.089 DB00318 0.114 0.084 DBMET00649 0.215 0.014 DB06409 0.131 0.066 DBMET00462 | DB06409 | |
| 0.131 | 0.188 | 0.254 | Vasodilator | 0.254 0.067 DB06409 0.251 0.068 DBMET00462 | DB06409 | |
| 0.028 | 0.089 | 0.042 | Microtubule stabilization | 0.042 0.039 DBMET00462 | DBMET00462 | |
| 0.071 | 0.135 | 0.111 | Cholesterol synthesis inhibitor | 0.111 0.074 DBMET00649 0.101 0.086 DBMET00462 | DBMET00649 | |
| 0.136 | 0.206 | 0.451 | Hypoglycemic | 0.451 0.02 DB06409 0.429 0.023 DBMET00462 | DB06409 | |
| 0.105 | 0.179 | 0.157 | Interferon gamma antagonist | 0.157 0.07 DB06409 0.139 0.094 DBMET00462 | DB06409 | |
| 0.218 | 0.294 | 0.409 | Caspase 9 stimulant | 0.26 0.241 DB00318 0.27 0.228 DB06409 0.409 0.105 DBMET00462 | DBMET00462 | |
| 0.028 | 0.104 | 0.069 | Alpha 1a adrenoreceptor antagonist | 0.069 0.052 DB00318 | DB00318 | |
| 0.012 | 0.091 | 0.043 | Protein 30S ribosomal subunit inhibitor | 0.036 0.011 DB06409 0.043 0.009 DBMET00462 | DBMET00462 | |
| 0.173 | 0.259 | 0.217 | Calcium channel activator | 0.217 0.189 DB00318 | DB00318 | |
| 0.064 | 0.159 | 0.157 | AMP-activated protein kinase stimulant | 0.157 0.024 DB06409 | DB06409 | |
| 0.095 | 0.196 | 0.138 | Adenylate cyclase stimulant | 0.138 0.084 DBMET00649 | DBMET00649 | |
| 0.026 | 0.135 | 0.05 | Alpha-mannosidase inhibitor | 0.05 0.043 DBMET00462 | DBMET00462 | |
| 0.131 | 0.248 | 0.246 | DNA synthesis inhibitor | 0.215 0.1 DBMET00649 0.246 0.069 DB06409 0.238 0.075 DBMET00462 | DB06409 | |
| 0.01 | 0.128 | 0.047 | 5 Hydroxytryptamine 2C agonist | 0.047 0.03 DBMET00649 | DBMET00649 | |
| 0.027 | 0.161 | 0.06 | Glucose-6-phosphate translocase inhibitor | 0.06 0.024 DB06409 | DB06409 | |
| 0.13 | 0.285 | 0.482 | Antithrombotic | 0.482 0.031 DB06409 0.42 0.044 DBMET00462 | DB06409 | |
| 0.023 | 0.179 | 0.077 | NMDA 2B receptor antagonist | 0.077 0.022 DBMET02313 | DBMET02313 | |
| 0.009 | 0.172 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 DBMET02313 | DBMET02313 | |
| 0.141 | 0.308 | 0.397 | Histamine release inhibitor | 0.397 0.077 DB06409 | DB06409 | |
| 0.123 | 0.295 | 0.391 | Vasodilator, coronary | 0.203 0.18 DB00318 0.273 0.112 DB06409 0.391 0.038 DBMET00462 | DBMET00462 | |
| 0.01 | 0.189 | 0.031 | Vanilloid 2 agonist | 0.031 0.008 DBMET00462 | DBMET00462 | |
| 0.006 | 0.194 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 DBMET00462 | DBMET00462 | |
| 0.008 | 0.212 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.015 DBMET00462 | DBMET00462 | |
| 0.053 | 0.271 | 0.451 | Angiogenesis stimulant | 0.43 0.017 DBMET02313 0.451 0.015 DB06409 0.369 0.028 DBMET00462 | DB06409 | |
| 0.094 | 0.351 | 0.136 | CC chemokine 6 receptor antagonist | 0.136 0.051 DB06409 | DB06409 | |
| 0.042 | 0.302 | 0.122 | Neurotrophic factor | 0.122 0.092 DBMET00462 | DBMET00462 | |
| 0.111 | 0.373 | 0.625 | Antibacterial | 0.221 0.206 DBMET00649 0.509 0.038 DB06409 0.625 0.016 DBMET00462 | DBMET00462 | |
| 0.087 | 0.373 | 0.384 | Cholesterol antagonist | 0.256 0.121 DB06409 0.384 0.053 DBMET00462 | DBMET00462 | |
| 0.058 | 0.362 | 0.247 | Insulin secretagoues | 0.158 0.066 DB06409 0.247 0.02 DBMET00462 | DBMET00462 | |
| 0.039 | 0.351 | 0.099 | Thioredoxin reductase inhibitor | 0.099 0.03 DBMET00462 | DBMET00462 | |
| 0.025 | 0.343 | 0.159 | Topoisomerase II inhibitor | 0.142 0.053 DB06409 0.159 0.045 DBMET00462 | DBMET00462 | |
| 0.018 | 0.339 | 0.106 | Topoisomerase II alpha inhibitor | 0.082 0.052 DB06409 0.106 0.036 DBMET00462 | DBMET00462 | |
| 0.02 | 0.355 | 0.142 | Topoisomerase I inhibitor | 0.109 0.063 DB06409 0.142 0.044 DBMET00462 | DBMET00462 | |
| 0.033 | 0.377 | 0.21 | Amylase inhibitor | 0.21 0.041 DBMET00462 | DBMET00462 | |
| 0.009 | 0.364 | 0.28 | Neuraminidase inhibitor | 0.28 0.003 DBMET00462 | DBMET00462 | |
| 0.009 | 0.368 | 0.269 | Selectin antagonist | 0.17 0.015 DBMET02313 0.228 0.009 DB06409 0.269 0.007 DBMET00462 | DBMET00462 | |
| 0.012 | 0.379 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.022 DB06409 | DB06409 | |
| 0.055 | 0.44 | 0.214 | ATPase inhibitor | 0.214 0.028 DBMET00462 | DBMET00462 | |
| 0.005 | 0.414 | 0.026 | Motilin receptor agonist | 0.026 0.012 DBMET00462 | DBMET00462 | |
| 0.011 | 0.427 | 0.344 | Neuraminidase (influenza) inhibitor | 0.344 0.003 DBMET00462 | DBMET00462 | |
| 0.038 | 0.461 | 0.228 | Platelet adhesion inhibitor | 0.228 0.057 DB06409 | DB06409 | |
| 0.03 | 0.455 | 0.142 | Cell wall synthesis inhibitor | 0.142 0.073 DB06409 | DB06409 | |
| 0.063 | 0.513 | 0.254 | Immunomodulator | 0.254 0.111 DB06409 | DB06409 | |
| 0.036 | 0.5 | 0.079 | T cell inhibitor | 0.079 0.07 DBMET00462 | DBMET00462 | |
| 0.032 | 0.515 | 0.151 | Hemostatic | 0.151 0.067 DB06409 | DB06409 | |
| 0.033 | 0.516 | 0.095 | Transcription factor NF kappa B stimulant | 0.088 0.054 DB06409 0.095 0.044 DBMET00462 | DBMET00462 | |
| 0.071 | 0.562 | 0.454 | Cyclophilin D inhibitor | 0.444 0.069 DB06409 0.454 0.065 DBMET00462 | DBMET00462 | |
| 0.01 | 0.52 | 0.061 | Cholecystokinin B agonist | 0.061 0.012 DBMET02313 | DBMET02313 | |
| 0.023 | 0.551 | 0.248 | Platelet antagonist | 0.248 0.073 DBMET00462 | DBMET00462 | |
| 0.012 | 0.605 | 0.134 | DNA intercalator | 0.134 0.05 DBMET00462 | DBMET00462 | |
| 0.019 | 0.623 | 0.122 | Cell adhesion inhibitor | 0.122 0.064 DBMET02313 0.104 0.082 DB06409 0.113 0.071 DBMET00462 | DBMET02313 | |
| 0.014 | 0.637 | 0.184 | Hypolipemic | 0.184 0.106 DBMET00462 | DBMET00462 | |
| 0.01 | 0.752 | 0.147 | Thrombolytic | 0.147 0.084 DB06409 | DB06409 | |
| 0.005 | 0.763 | 0.049 | Elastase inhibitor | 0.049 0.044 DBMET02313 | DBMET02313 | |
| 0.005 | 0.847 | 0.078 | Cell adhesion molecule inhibitor | 0.078 0.056 DBMET02313 | DBMET02313 | |
| 0.01 | 0.875 | 0.079 | Factor IXa inhibitor | 0.079 0.016 DBMET02313 | DBMET02313 | |
| 0.005 | 0.871 | 0.279 | Anticoagulant | 0.279 0.032 DBMET02313 | DBMET02313 | |
| 0.002 | 0.891 | 0.033 | Cholecystokinin agonist | 0.033 0.009 DBMET02313 | DBMET02313 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |